MCF Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

MCF Advisors’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.5M	Buy	257,910 +2,926	+1%	+$73.7K	0.23%	59
2026 Q1	$6.44M	Buy	254,984 +148,486	+139%	+$3.79M	0.28%	48
2025 Q4	$2.72M	Buy	106,498 +1,454	+1%	+$37.2K	0.15%	73
2025 Q3	$2.69M	Buy	105,044 +1,117	+1%	+$28.3K	0.16%	51
2025 Q2	$2.63M	Buy	103,927 +3,155	+3%	+$78.3K	0.17%	49
2025 Q1	$2.52M	Buy	100,772 +4,751	+5%	+$118K	0.18%	46
2024 Q4	$2.36M	Buy	96,021 +1,459	+2%	+$36.5K	0.17%	48
2024 Q3	$2.43M	Buy	94,562 +1,082	+1%	+$27.3K	0.17%	50
2024 Q2	$2.3M	Buy	93,480 +1,078	+1%	+$26.3K	0.17%	49
2024 Q1	$2.29M	Buy	92,402 +3,587	+4%	+$88.9K	0.18%	46
2023 Q4	$2.24M	Buy	88,815 +1,394	+2%	+$33.3K	0.18%	47
2023 Q3	$2.05M	Buy	87,421 +83,732	+2,270%	+$2.02M	0.19%	48
2023 Q2	$90.8K	Hold	3,689	–	–	0.01%	301
2023 Q1	$92.5K	Hold	3,689	–	–	0.01%	291
2022 Q4	$89.2K	Buy	+3,689	New	+$88.6K	0.01%	288

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

MCF Advisors's IBDX Position: Q2 2026 in Review

MCF Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.1% in Q2 2026, buying an estimated $73.7K and bringing the position to 257,910 shares worth $6.5M. The position accounts for 0.23% of the portfolio, ranked #59.

MCF Advisors first reported a position in IBDX in Q4 2022 and has held it in 15 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

MCF Advisors held 257,910 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $6.5M as of Q2 2026.
MCF Advisors bought 2,926 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $73.7K.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.23% of MCF Advisors's portfolio in Q2 2026, its #59 holding.
MCF Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.